RYAHF (RYAH Group) FCF Margin %: -1,450.00% (As of Sep. 2022)


What is RYAH Group FCF Margin %?

RYAH Group RYAHF FCF Margin % is -1,450.00% as of Sep. 2022.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. RYAH Group's Free Cash Flow for the three months ended in Sep. 2022 was $-0.12 Mil. RYAH Group's Revenue for the three months ended in Sep. 2022 was $0.01 Mil. Therefore, RYAH Group's FCF Margin % for the quarter that ended in Sep. 2022 was -1,450.00%.

As of today, RYAH Group's current FCF Yield % is 0.00%.

The historical rank and industry rank for RYAH Group's FCF Margin % or its related term are showing as below:

RYAHF' s FCF Margin % Range Over the Past 10 Years
Min: -483.2   Med: 0   Max: 0
Current: -483.2

RYAHF's FCF Margin % is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 3.39 vs RYAHF: -483.20

RYAH Group FCF Margin % Related Terms

RYAH Group FCF Margin % Historical Data

* Premium members only.

The historical data trend for RYAH Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RYAH Group FCF Margin % Chart

RYAH Group Annual Data
Trend Dec20 Dec21
FCF Margin %
-1,132.56 -1,883.93

RYAH Group Quarterly Data
Feb20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 -571.43 -1,450.00

RYAHF vs CERN, VEEV, CHNG: FCF Margin % Comparison

For the Health Information Services subindustry, RYAH Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RYAH Group FCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RYAH Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where RYAH Group's FCF Margin % falls into.


RYAH Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

RYAH Group's FCF Margin for the fiscal year that ended in Dec. 2021 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-3.165/0.168
=-1,883.93 %

RYAH Group's FCF Margin for the quarter that ended in Sep. 2022 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-0.116/0.008
=-1,450.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -1,450.00% mean?
RYAH Group (RYAHF) has a FCF Margin % of -1,450.00% as of Sep. 2022. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on RYAH Group and its competitors.
Is RYAH Group's FCF Margin % too high?
RYAH Group's current FCF Margin % is -1,450.00%.
How does RYAH Group's FCF Margin % compare to CERN and VEEV?
RYAH Group's FCF Margin % of -1,450.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median FCF Margin % is 3.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on RYAH Group and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RYAH Group's current FCF Margin % is -1,450.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RYAH Group stock overvalued right now?
RYAH Group (RYAHF) has a current FCF Margin % of -1,450.00%. The current FCF Margin % is -1,450.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For RYAH Group (RYAHF), the current FCF Margin % is -1,450.00% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RYAH Group Business Description

Address 68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.